We are live on ! Find out more
MSKCC

Memorial Sloan Kettering Cancer Center Portfolio holdings

AUM $24.6M
1-Year Est. Return 10.16%
This Fund
S&P 500
This Quarter Est. Return
+16.63%
1 Year Est. Return
+10.16%
3 Year Est. Return
-14.79%
5 Year Est. Return
10 Year Est. Return
AUM
$30.3M
AUM Growth
+$896K
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 30.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GDX icon
1
VanEck Gold Miners ETF
GDX
$27.4B
$21.2M 69.82%
738,500
ORIC icon
2
Oric Pharmaceuticals
ORIC
$1.37B
$3.55M 11.7%
602,272
CRBU icon
3
Caribou Biosciences
CRBU
$163M
$3.42M 11.27%
544,196
ILMN icon
4
Illumina
ILMN
$28.9B
$1.25M 4.13%
6,360
YMAB
5
DELISTED
Y-mAbs Therapeutics
YMAB
$933K 3.08%
191,176

Similar funds

Memorial Sloan Kettering Cancer Center's Q4 2022 Portfolio in Review

As of Q4 2022, Memorial Sloan Kettering Cancer Center held 5 positions worth $30.3M, up 3% from $29.4M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2022: portfolio turnover was 0%. Memorial Sloan Kettering Cancer Center opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 39% a quarter earlier.

  • Memorial Sloan Kettering Cancer Center's ten largest holdings make up 100% of its $30.3M portfolio in Q4 2022.
  • Memorial Sloan Kettering Cancer Center opened 0 new positions and closed 0 in Q4 2022.
  • Memorial Sloan Kettering Cancer Center's portfolio value rose 3% quarter-over-quarter to $30.3M.

Based on Memorial Sloan Kettering Cancer Center's 13F filing for Q4 2022, filed 10 Feb 2023.